GMED has extensive experience with a team specialized in assessing medical devices incorporating medicinal substances under Regulation (EU) 2017/745 (analyzing the proof of usefulness of adding the medicinal substance, and managing consultations by communicating with the competent authorities for the quality & safety component and analyzing the benefit/risk profile).

Tell us about your projects by completing this questionnaire (< 1 mn).




Find an answer to the challenges you are facing in one of our upcoming events: trainings, webinars, forums...

Learn more